Navigation Links
Altheus Therapeutics Completes Phase I Clinical Study of Zoenasa™ in Ulcerative Colitis
Date:1/6/2011

OKLAHOMA CITY, Jan. 6, 2011 /PRNewswire/ -- Altheus Therapeutics, Inc., announced that it has completed a two dose, double-blind, active-controlled Phase I clinical trial of the safety and tolerability of Zoenasa™ Rectal Suspension in adult patients with left-sided, or distal, ulcerative colitis.  No serious adverse events were experienced by patients in this study.  "We are excited to have achieved this milestone, as it prepares Altheus to begin our planned Phase II clinical program to definitively evaluate the safety and efficacy of Zoenasa in ulcerative colitis patients," commented Dennis Schafer, President and CEO of Altheus.

Nearly 1.2 million Americans suffer from inflammatory bowel disease. The two most common forms, ulcerative colitis and Crohn's disease, are chronic lifelong conditions which significantly impact the quality of life. Front-line treatment for ulcerative colitis is monotherapy with oral or rectal mesalamine.  However many patients do not achieve remission and must escalate to more expensive and risky treatments.

Zoenasa is a novel combination of two FDA-approved drugs with well established efficacy and safety records that have been shown to act synergistically for the treatment of ulcerative colitis.  In animal models of colitis, Zoenasa resolved inflammation more rapidly and completely than standard mesalamine treatment.  Zoenasa Rectal Suspension is being investigated for the treatment of left-sided ulcerative colitis, which affects approximately 80% of ulcerative colitis patients.  The U.S. Food and Drug Administration has granted Zoenasa orphan designation for the treatment of pediatric ulcerative colitis.  An oral formulation of Zoenasa is in pre-clinical development.

Altheus Therapeutics, Inc., of Oklahoma City, is a pharmaceutical development company focused on innovative therapies for the treatment of inflammatory bowel disease. Contact:Dennis Schafer, CEO

SOURCE Altheus Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
3. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
4. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
5. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
6. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
7. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
8. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
9. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
10. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
11. Cell Therapeutics, Inc. (CTI) Sponsors Panel Discussion on Women and Lung Cancer on Capitol Hill
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... 2015 Even the Score today announced the ... as scientific co-chair for the coalition. Dr. Larkin will ... an expert voice in the important conversation regarding the ... with Hypoactive Sexual Desire Disorder (HSDD), women,s most common ... honored to join Even the Score as its co-chair ...
(Date:7/27/2015)... 20, 2015 Research and Markets ( http://www.researchandmarkets.com/research/t63pbj/medical_device ... Device Regulation in Asia/Pacific Markets Seminar" conference to ... Medical Device market is well established, the next growth ... China , together with other countries in this ... of implementing, their own medical device regulations. This seminar ...
(Date:7/27/2015)... 27, 2015 Research and Markets ... of the "Wound Care -Traditonal, Advanced ... Analysis And Forecasts" report to their ... evaluation of the global Wound Care products ... product offerings, competitive shares, financial performance, technology ...
Breaking Medicine Technology:Dr. Lisa Larkin Joins the Even the Score Coalition as Scientific Co-Chair 2Dr. Lisa Larkin Joins the Even the Score Coalition as Scientific Co-Chair 3Medical Device Regulation in Asia/Pacific Markets Seminar: London, UK - 21st, 22nd of September 2015 2Global Wound Care Markets 2015-2020 - Traditonal, Advanced And Regenerative: Competitors And Opportunities 2
... Biopharmaceuticals, Inc. (NASDAQ: KERX ), a biopharmaceutical ... medically important pharmaceutical products for the treatment of cancer ... will be held on Monday, August 8, 2011 at ... quarter ended June 30, 2011 and a business outlook ...
... and SYDNEY, Aug. 4, 2011 HeartWare International, Inc. ... innovator of less invasive, miniaturized circulatory support technologies that ... announced revenues of $20.4 million for the second quarter ... increase from $9.8 million in revenues for the same ...
Cached Medicine Technology:Keryx Biopharmaceuticals, Inc. to Host Conference Call on Second Quarter 2011 Financial Results 2HeartWare International Reports Second Quarter 2011 Revenues of $20.4 Million; 109% Increase From $9.8 Million in Second Quarter 2010 2HeartWare International Reports Second Quarter 2011 Revenues of $20.4 Million; 109% Increase From $9.8 Million in Second Quarter 2010 3HeartWare International Reports Second Quarter 2011 Revenues of $20.4 Million; 109% Increase From $9.8 Million in Second Quarter 2010 4HeartWare International Reports Second Quarter 2011 Revenues of $20.4 Million; 109% Increase From $9.8 Million in Second Quarter 2010 5HeartWare International Reports Second Quarter 2011 Revenues of $20.4 Million; 109% Increase From $9.8 Million in Second Quarter 2010 6
(Date:7/28/2015)... ... July 28, 2015 , ... The joint SCAN ... such as reducing high-risk medication use and improving compliance with diabetes treatment guidelines. ... behaviors and outcomes, this unique-in-the-industry Quality Network Program may be paving the way ...
(Date:7/28/2015)... ... July 28, 2015 , ... Headaches are the number one neurological ... close second. Clients suffering from headaches and back pain often find relief by seeking ... The Joint 's nine offices in the St. Louis area welcome new clients ...
(Date:7/28/2015)... ... 28, 2015 , ... North American Seminars will present seventeen ... 2015 . These seventeen courses are pre-approved for CME credit for Physical ... in the Older Adult , August 22, 2015 - August 23, 2015 ...
(Date:7/28/2015)... ... July 28, 2015 , ... ... for Invisalign. Invisalign is a revolutionary orthodontic treatment that allows patients to straighten ... Mozafari’s expertise and 3D computer imaging technology. You wear each set of aligners ...
(Date:7/27/2015)... ... July 28, 2015 , ... Dr. Robert G. Schwartz ... practice has teamed up with Realief Neuropathy Centers in order to offer his patients ... the signs and symptoms of peripheral neuropathy. , Peripheral neuropathy is a disease caused ...
Breaking Medicine News(10 mins):Health News:SCAN/Express Scripts MA Pharmacy Quality Network Program to be Featured in Upcoming AIS Webinar 2Health News:SCAN/Express Scripts MA Pharmacy Quality Network Program to be Featured in Upcoming AIS Webinar 3Health News:The Joint St. Louis Offers “2 for Thursday” Special, Chiropractic Care Services, Affordable Back Pain Relief 2Health News:North American Seminars receives California PT Board approval for Seventeen Continuing Education Courses presented in the Fall of 2015. 2Health News:North American Seminars receives California PT Board approval for Seventeen Continuing Education Courses presented in the Fall of 2015. 3Health News:North American Seminars receives California PT Board approval for Seventeen Continuing Education Courses presented in the Fall of 2015. 4Health News:North American Seminars receives California PT Board approval for Seventeen Continuing Education Courses presented in the Fall of 2015. 5Health News:North American Seminars receives California PT Board approval for Seventeen Continuing Education Courses presented in the Fall of 2015. 6Health News:North American Seminars receives California PT Board approval for Seventeen Continuing Education Courses presented in the Fall of 2015. 7Health News:North American Seminars receives California PT Board approval for Seventeen Continuing Education Courses presented in the Fall of 2015. 8Health News:Cupertino Invisalign Dentist, Dr. Setareh Mozafari, is Now Offering Complimentary Consultations for Invisalign 2Health News:Piedmont Physical Medicine & Rehabilitation, P.A. Partners with Realief® Neuropathy Centers to Offer Peripheral Neuropathy Laser Treatment 2
... a further death linked to the superbug Clostridium// difficile (C-diff). ... diarrhea and more serious intestinal conditions such as colitis. ... at the James Paget University Hospital (JPH), Gorleston, linked to ... people have had to undergo major bowel surgery. ...
... for space with stories on bird flu. After all, it ... that pets may be the only ones who need to ... insight, an arsenic-based additive that forms an ingredient in chicken ... this chicken. , ,Roxarsone, the wide spread arsenic-based ...
... for bipolar disorder, increases the amount// of gray matter ... ,The research is featured in the ... currently available online. ,Carrie Bearden, a ... and Paul Thompson, associate professor of neurology at the ...
... – Type 1 diabetic patients could be bailed out with ... ,Stem cell therapy proved helpful for patients suffering Type-1 ... for months and in one particular case a patient went ... participated in the testing, 13 completely stayed-off insulin injections. ...
... sufferer among Indian cities with flash rains, floods and fall ... an international report on climate change. ,According to the ... (IPCC), the rise in sea level and flooding of villages ... ,"Since Mumbai has reclaimed ocean land substantially, they are ...
... seeking judicial intervention for enactment of a law on the ... to instead approach the government. ,A division bench ... advocate Namita Roy to approach the ministries of social welfare ... valid laws, rules and regulation on the sensitive issue. ...
Cached Medicine News:Health News:Hospital Infection Deaths Continue in UK 2Health News:Lithium Increases Gray Matter in Bipolar Brains 2Health News:Kolkata, Mumbai to Face Maximum Brunt of Climate Change 2
... Symphony II Platelet Concentrate System is ... preparation of Platelet Concentrate (also referred to ... Platelet Poor Plasma (PPP) from a small ... concentrates the body's natural growth factors, which ...
... factors (AGF) technology. Using the ... gel delivers a cocktail of ... proteins in high concentrations that ... new bone cells and promote ...
... Dual Imaging Color Module Leica combines precision microscopy ... important and necessary patient data can be displayed ... optical platform on the Leica OH3, OHS1, MS3 ... highest brightness, contrast >300:1, true color and resolution ...
... 2D video system offers you ... video imaging. The Leica 2D ... module to fit on all ... 2D C-mount for an installation ...
Medicine Products: